Biotech · Private company
Dren Bio
Track this companyFree. Adds Dren Bio to your Dealase workspace and tells you when its record changes.
Clinical trials44 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Dibotatug (DR-01)Phase 2 · Bone Marrow Failure SyndromesClinicalTrials.gov · fetched Nov 12, 2026
- DR-01Phase 2 · LGLL - Large Granular Lymphocytic LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- DR-01Phase 1 · Alopecia AreataClinicalTrials.gov · fetched Nov 12, 2026
- DR-0202Phase 1 · Triple Negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure SyndromesPHASE1_PHASE2 · RECRUITING · started Aug 14, 2026ClinicalTrials.gov NCT07712562 · fetched Nov 12, 2026
- A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory CarcinomasPHASE1 · RECRUITING · started Jun 3, 2025ClinicalTrials.gov NCT06999187 · fetched Nov 12, 2026
- A Study of DR-01 in Subjects With Alopecia Areata and VitiligoPHASE1 · ACTIVE_NOT_RECRUITING · started Oct 30, 2024ClinicalTrials.gov NCT06602232 · fetched Nov 12, 2026
- A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic LymphomasPHASE1_PHASE2 · RECRUITING · started Jul 13, 2022ClinicalTrials.gov NCT05475925 · fetched Nov 12, 2026